Arthritis Urica (Gout) – Causes, Symptoms & Treatment

Arthritis Urica – Gout: Causes, Symptoms and Treatment

Arthritis urica, commonly known as gout, is an inflammatory joint disease caused by elevated uric acid levels in the blood, a condition referred to as hyperuricaemia. When uric acid exceeds its saturation threshold, it crystallises as monosodium urate and deposits in joints, bursae and surrounding soft tissues. These crystal deposits trigger intense inflammatory responses known as acute gout attacks.

Causes and Risk Factors

Uric acid is produced during the breakdown of purines, compounds found in abundance in certain foods such as red meat, organ meats, shellfish and alcoholic beverages, particularly beer. Several factors increase the risk of developing gout:

• High-purine diet
• Alcohol consumption, especially beer and spirits
• Obesity and metabolic syndrome
• Renal insufficiency with reduced uric acid excretion
• Genetic predisposition
• Certain medications, such as thiazide diuretics
• Male sex and older age

Symptoms

An acute gout attack typically begins suddenly, often at night, with extremely severe pain in a single joint. The most commonly affected joint is the metatarsophalangeal joint of the big toe, a condition known as podagra. Other frequent sites include the ankle, knee, wrist and elbow. The affected joint is typically:

• Markedly swollen
• Red and warm to the touch
• Exceptionally tender even to light pressure
• Restricted in its range of movement

Without treatment, attacks resolve within days to two weeks. In chronic gout, tophi – visible urate deposits under the skin – and permanent joint damage may develop over time.

Diagnosis

Diagnosis is based on the characteristic clinical presentation, measurement of serum uric acid levels and imaging techniques such as ultrasound or X-ray. The gold standard remains the identification of urate crystals in synovial fluid under polarised light microscopy. In patients with gout, serum uric acid should be maintained permanently below 6 mg/dL.

Treatment

Acute Treatment

During an acute attack, anti-inflammatory medications are the mainstay of therapy: Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen or indomethacin, colchicine or corticosteroids. Early initiation of treatment within the first hours of an attack is essential for rapid relief.

Long-term Treatment and Urate Lowering

For recurrent or chronic gout, long-term urate-lowering therapy is initiated. Allopurinol and febuxostat inhibit uric acid synthesis and are the first-line agents. The therapeutic goal is to reduce serum uric acid permanently below the saturation threshold to prevent future attacks and tophi formation.

Diet and Lifestyle

Dietary modification plays an important supporting role: purine-rich foods and alcohol should be reduced, and fluid intake should be increased. Adequate hydration with water and low-sugar beverages promotes renal uric acid excretion. Weight reduction in overweight individuals can meaningfully lower uric acid levels.

Supporting Joint Health in the Long Term

Alongside medical treatment and lifestyle adjustments, many people with gout seek additional measures to support joint health. High-quality nutrient combinations can play a complementary role as part of a balanced diet. For more information on a supplement specifically developed for joint support, visit the product page for the artgerecht Gelenk Komplex UC-II joint supplement.

Since long-term joint integrity is a central concern in gout management, a sustained strategy is essential. In addition to consistent urate-lowering therapy, targeted nutrients may help support cartilage health. Further details are available on the artgerecht Gelenk Komplex UC-II product page.

Those who wish to maintain joint mobility and function over the long term should consider targeted nutritional support alongside gout therapy. Our Gelenk Komplex UC-II for comprehensive joint support provides further information on this topic.

Frequently Asked Questions

What is the difference between gout and arthritis urica?

Arthritis urica is the medical Latin term for gout. Both terms refer to the same condition: an inflammatory joint disease caused by the deposition of uric acid crystals in joints and surrounding tissues. In everyday clinical practice, the term gout is most commonly used, while arthritis urica appears primarily in medical and scientific literature.

Which foods should I avoid if I have gout?

Foods high in purines should be limited: organ meats such as liver and kidneys, red meat, game, shellfish and alcohol, especially beer. Fructose-rich beverages and sweets can also raise uric acid levels. Dietary counselling by a physician or dietitian is strongly recommended for personalised guidance.

Is gout curable or only manageable?

In most cases, gout is highly manageable but not curable in the sense of a permanent resolution without ongoing treatment. With consistent urate-lowering medication, an adapted diet and a healthy lifestyle, most patients can remain entirely symptom-free and prevent permanent joint damage from developing.

Why does gout occur more frequently in men?

Oestrogen promotes renal uric acid excretion in women, which is why premenopausal women develop gout far less often. After menopause, the risk equalises. Men generally have higher baseline uric acid levels and develop gout more frequently, often from middle age onwards.

How quickly does treatment of an acute gout attack work?

When treatment is initiated early within the first hours of an attack, NSAIDs or colchicine can significantly reduce inflammation within one to three days. Full resolution of the attack typically takes several days to up to two weeks, depending on the severity and how promptly treatment is started.

What complications can chronic gout cause?

Untreated or poorly controlled chronic gout can lead to permanent joint damage, the formation of tophi (visible urate nodules beneath the skin), kidney stones and progressive decline in kidney function. Gout is also associated with an increased risk of cardiovascular disease.

References

1. Richette P, Doherty M, Pascual E et al. 2016 updated EULAR evidence-based recommendations for the management of gout. Annals of the Rheumatic Diseases. 2017;76(1):29–42.
2. Dalbeth N, Merriman TR, Stamp LK. Gout. The Lancet. 2016;388(10055):2039–2052.
3. Neogi T. Gout. The New England Journal of Medicine. 2011;364(5):443–452.